We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
NeuroMetrix, a medical device company focused on the development and sale of
proprietary products used to diagnose neuropathies, announced that it has joined
Eli Lilly in an Education & Development Program to improve awareness and
detection of diabetic peripheral neuropathy.
Natus Medical announced the signing of a private label agreement with Fisher
& Paykel, a manufacturer of neonatal warmers, resuscitators and respiratory
care devices.
Orthovita, a developer of synthetic biomaterials for the orthopedic market,
announced that it has been granted a U.S. patent covering the development and
use of composite shaped bodies for a range of applications in orthopedic surgery.
Advanced Neuromodulation Systems has received FDA approval to market and sell
its second rechargeable implantable pulse generator (IPG), the Eon Neurostimulation
System.
The FDA has approved Boston Scientific's Quincy Distribution Center as a sterilization
site for its Cutting Balloon microsurgical dilatation device product line, the
company said.
Conor Medsystems, a developer of controlled vascular drug delivery technologies,
has signed an agreement with Novartis Pharma granting Conor the right to evaluate
three Novartis pharmaceutical compounds for the potential development of a product
combining a Novartis compound with Conor's reservoir-based drug-eluting stents
for the treatment of vascular diseases.
Biophan Technologies, a developer of next-generation biomedical technology,
announced plans to begin animal trials of its advanced MRI-imageable vena cava
filter, in a research program underway at the company's newly established Biophan-Europe
division.